Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Equity Ratio (2022 - 2026)

HeartSciences filings provide 5 years of Equity Ratio readings, the most recent being 0.35 for Q1 2026.

  • On a quarterly basis, Equity Ratio rose 12.07% to 0.35 in Q1 2026 year-over-year; TTM through Jan 2026 was 0.35, a 12.07% increase, with the full-year FY2025 number at 0.05, down 93.69% from a year prior.
  • Equity Ratio hit 0.35 in Q1 2026 for HeartSciences, down from 0.7 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.8 in Q1 2024 to a low of 2.9 in Q2 2022.
  • Median Equity Ratio over the past 5 years was 0.33 (2025), compared with a mean of 0.1.
  • Biggest five-year swings in Equity Ratio: tumbled 406.93% in 2023 and later soared 1178.7% in 2024.
  • HeartSciences' Equity Ratio stood at 0.23 in 2022, then tumbled by 406.93% to 0.7 in 2023, then soared by 174.15% to 0.52 in 2024, then soared by 35.06% to 0.7 in 2025, then crashed by 49.67% to 0.35 in 2026.
  • The last three reported values for Equity Ratio were 0.35 (Q1 2026), 0.7 (Q4 2025), and 0.49 (Q3 2025) per Business Quant data.